ID    AVR/I/SSAP183
ET    Non-clinical
PN    Omiganan (Indolicidin analog)
PL    12 [Note: any special compound, if present in sequence, is not considered in length]
SR    Not available
SO    Synthetic peptide
TX    Not available
VL    Experimentally validated
XX
TO    VRSA-19
IC    MIC = 16 microG/ML
TH    Topical antimicrobial agent in phase III of a clinical trial
XR    PubMed: 18178361
XR    PubMed: 34360692
XR    RCSB PDB/PDBsum/PDBe/PDBj/PDBe-KB/MMDB: Not available 
XR    UniProt: Not available
XR    DrugBank: DB06610
XX
SQ    SEQUENCE  
      ILRWPWWPWR RK-amide 
//

